Tianshili\'s announcement on participating in the 2024 semi-annual report performance briefing for listed companies in Tianjin and an online investor reception day
Tasly Pharmaceutical Group Announcement on the Company's Main Business Data for the First Half of 2024
Announcement of the resolution of the second meeting of the ninth supervisor meeting of Tasly Pharmaceutical Group.
Announcement of the resolutions of the 3rd meeting of the 9th board of directors of Tasly Pharmaceutical Group
Announcement of Progress on Tasly Pharmaceutical Group Providing Guarantees for its Subsidiaries.
HUATAI United Securities Co., Ltd's Financial Advisor Verification Opinion on the Detailed Equity Change Report of Tasly Pharmaceutical Group Co., Ltd.
Tianshili's progress announcement on providing guarantees to subsidiaries
Announcement of Resolutions of the 1st Meeting of the 9th Board of Directors of Tasly
Announcement of Resolutions of the 1st Meeting of the 9th Board of Supervisors of Tasly
Tianshili's announcement on the company's main operating data for the first quarter of 2024
Tianshili 2023 Social Responsibility Report
2023 Independent Director Debriefing Report (Wang Aijian)
2023 Independent Director's Debriefing Report (Xin Liu)
Tianshili 2023 Audit Report
2023 Accounting Firm Performance Assessment Report
Tianshili\'s announcement on the use of idle funds for delegated financial management in 2024
Tianshili\'s announcement on the renewal of the 2024 accounting firm
Resolutions of the first special meeting of independent directors of the 8th board of directors of Tasly in 2024
Announcement of Resolutions of the 26th Meeting of the Eighth Board of Directors of Tasly
Tianshili\'s announcement on the company\'s main operating data for 2023
No Data
No Data